Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients
Status:
Completed
Trial end date:
2018-01-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the safety, efficacy, and pharmacokinetics of a
regimen of atazanavir powder boosted with ritonavir and an optimized dual nucleoside reverse
transcriptase inhibitor in pediatric patients aged ≥3 months to <11 years.